The Federal Trade Commission (FTC) pressed ahead with its challenge of Qualcomm’s licensing practices on Thursday, August 30, asking a California federal court to find that the company is required to license its standard essential patents (SEPs) to rival chipmakers.
The FTC filed its motion for partial summary judgment at the US District Court for the Northern District of California, San Jose Division, on August 30. Qualcomm’s competition dispute with the FTC is due to be heard at trial in January 2019.
However, four months before the trial is due to commence, the FTC has asked the court for partial summary judgment that, under the fair, reasonable, and non-discriminatory (FRAND) licensing obligations Qualcomm committed to when it participated in setting wireless standards, Qualcomm must license its SEPs to rival chip makers.
The Commission’s lawsuit, submitted in January last year, alleges that Qualcomm had unlawfully maintained a monopoly in the market for baseband processors.
The motion filed by the FTC last week emphasised Qualcomm’s contractual commitments to make SEP licences available on FRAND terms, including to those entities which are considered competitors.
Foss Patents, a patent blog, said the motion is “legally extremely simple, yet has the potential for truly transformative impact on the marketplace.”
It explained that, if Judge Koh grants the motion, companies such as Samsung and Intel are likely to ask Qualcomm for a licence to its wireless SEPs on FRAND terms.
Qualcomm would then receive royalties representing a FRAND percentage of chip prices, rather than that of an entire mobile device, and prices for competitors and device makers would be reduced, according to Foss Patents.
Full Content: WIPR
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas